Gray, M., Gong, J., Nguyen, V., Osada, T., Hartman, Z., Hutchins, J., … Lyerly, K. (2015). Targeting of phosphatidylserine by monoclonal antibodies augments the activity of paclitaxel and anti-PD1/PD-L1 therapy in the murine breast model E0771. Journal for Immunotherapy of Cancer, 3(Suppl 2), P357–P357. https://doi.org/10.1186/2051-1426-3-s2-p357

Gray, Michael, Jian Gong, Van Nguyen, Takuya Osada, Zachary Hartman, Jeff Hutchins, Bruce Freimark, and Kim Lyerly. “Targeting of phosphatidylserine by monoclonal antibodies augments the activity of paclitaxel and anti-PD1/PD-L1 therapy in the murine breast model E0771.” Journal for Immunotherapy of Cancer 3, no. Suppl 2 (January 2015): P357–P357. https://doi.org/10.1186/2051-1426-3-s2-p357.

Gray M, Gong J, Nguyen V, Osada T, Hartman Z, Hutchins J, et al. Targeting of phosphatidylserine by monoclonal antibodies augments the activity of paclitaxel and anti-PD1/PD-L1 therapy in the murine breast model E0771. Journal for immunotherapy of cancer. 2015 Jan;3(Suppl 2):P357–P357.

Gray, Michael, et al. “Targeting of phosphatidylserine by monoclonal antibodies augments the activity of paclitaxel and anti-PD1/PD-L1 therapy in the murine breast model E0771.” Journal for Immunotherapy of Cancer, vol. 3, no. Suppl 2, Jan. 2015, pp. P357–P357. Epmc, doi:10.1186/2051-1426-3-s2-p357.

Gray M, Gong J, Nguyen V, Osada T, Hartman Z, Hutchins J, Freimark B, Lyerly K. Targeting of phosphatidylserine by monoclonal antibodies augments the activity of paclitaxel and anti-PD1/PD-L1 therapy in the murine breast model E0771. Journal for immunotherapy of cancer. 2015 Jan;3(Suppl 2):P357–P357.